1-20 of 82
Keywords: April
Sort by
Journal Article
Xingku Li and others
Clinical and Experimental Immunology, Volume 216, Issue 2, May 2024, Pages 211–219, https://doi.org/10.1093/cei/uxad128
Published: 27 December 2023
... ligand (APRIL) signaling (TACI-Fc + AMR). Pathological changes were assessed using hematoxylin–eosin and immunohistochemical staining. Banff values were evaluated using the Banff 2015 criteria. Donor-specific antibody (DSA) levels were assessed using flow cytometry, and BAFF and APRIL concentrations were...
Journal Article
See Cheng Yeo and Jonathan Barratt
Clinical Kidney Journal, Volume 16, Issue Supplement_2, December 2023, Pages ii9–ii18, https://doi.org/10.1093/ckj/sfad200
Published: 04 December 2023
... ligand (APRIL), a tumour necrosis factor (TNF) superfamily cytokine involved in B-cell signalling [ 20 , 21 ], and its function in driving IgA class switch recombination and production [ 22 ] and survival of IgA-secreting plasma cells [ 23 ] has become increasingly acknowledged as likely to play a key...
Journal Article
Yasuhiro Shimojima and others
Clinical and Experimental Immunology, Volume 213, Issue 1, July 2023, Pages 125–137, https://doi.org/10.1093/cei/uxad024
Published: 16 February 2023
...Yasuhiro Shimojima; Dai Kishida; Takanori Ichikawa; Ryota Takamatsu; Shun Nomura; Yoshiki Sekijima Serum samples were stored at −80 °C until ELISA was performed. We used ELISA kits for measuring serum concentrations of BAFF (R&D system, Minneapolis, MN, USA), APRIL (eBioscience, Vienna, Austria...
Journal Article
Nathalie Sturm and others
Journal of Leukocyte Biology, Volume 113, Issue 4, April 2023, Pages 376–382, https://doi.org/10.1093/jleuko/qiad014
Published: 07 February 2023
... ligand (APRIL), a key factor from the TNF superfamily for PC homeostasis, in eosinophils from the lower intestine. We observed a strong heterogeneity, since duodenum eosinophils did not produce APRIL at all, whereas a large majority of eosinophils from the ileum and right colon produced...
Journal Article
Mateusz Marcisz and others
Glycobiology, Volume 31, Issue 7, July 2021, Pages 772–786, https://doi.org/10.1093/glycob/cwab016
Published: 04 March 2021
...Mateusz Marcisz; Bertrand Huard; Agnieszka G Lipska; Sergey A Samsonov Abstract A proliferation-inducing ligand (APRIL) is a member of the tumor necrosis factor superfamily. APRIL is quite unique in this superfamily for at least for two reasons: (i) it binds to glycosaminoglycans (GAGs) via its...
Journal Article
Daniel J Wallace and others
Rheumatology, Volume 60, Issue 11, November 2021, Pages 5379–5389, https://doi.org/10.1093/rheumatology/keab115
Published: 06 February 2021
...-term treatment with atacicept 150 mg in SLE patients had an acceptable safety profile, with durable efficacy. Trial registration ClinicalTrials.gov, http://clinicaltrials.gov , NCT02070978. systemic lupus erythematosus atacicept TACI APRIL/BLyS inhibitor long-term extension study EMD Serono...
Journal Article
Hiroki Yamaguchi and others
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 75–86, https://doi.org/10.1093/ndt/gfaa223
Published: 25 October 2020
... provide evidence that aberrant mucosal immune responses to tonsillar anaerobic microbiota, primarily consisting of members of the phylum Bacteroidetes, are involved in IgAN pathophysiology. APRIL IgA nephropathy immunoglobulin repertoire sequencing microbiome tonsillectomy KEY LEARNING POINTS...
Journal Article
Takahiro Kawakami and others
Nephrology Dialysis Transplantation, Volume 34, Issue 6, June 2019, Pages 960–969, https://doi.org/10.1093/ndt/gfy296
Published: 15 October 2018
... macrophages, a membrane-bound form of APRIL (Stalk-1) for APRIL-producing cells and a soluble form of APRIL (Aprily-8) for secreted APRIL. The immunostaining was performed using a monoclonal antibody against human IgG4 (clone HP6025, fully diluted; Nichirei, Tokyo, Japan), CD138 (clone B-B4, 1:100; AbD...
Journal Article
Tamer A Gheita and others
Modern Rheumatology, Volume 23, Issue 3, 1 May 2013, Pages 542–546, https://doi.org/10.3109/s10165-012-0694-x
Published: 01 May 2013
... concentration of B-cell activating factors, B lymphocyte stimulators (BLyS), and a proliferation-inducing ligand (APRIL) in Behçet disease (BD) patients in order to evaluate their role and study their relation to uveitis subtype and disease activity. Methods The study included 58 consecutively...
Journal Article
Takumi Furuya and others
Modern Rheumatology, Volume 22, Issue 4, 1 August 2012, Pages 541–549, https://doi.org/10.3109/s10165-011-0539-z
Published: 01 August 2012
.../open_access/funder_policies/chorus/standard_publication_model ) Mod Rheumatol (2012) 22:541 549 DOI 10.1007/s10165-011-0539-z ORIGINAL ARTICLE Effects of APRIL (TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL Takumi Furuya Minori Koga Koki Hikami Aya Kawasaki Naoyuki...
Journal Article
Yuan Zhao and others
Rheumatology, Volume 51, Issue 9, September 2012, Pages 1580–1586, https://doi.org/10.1093/rheumatology/kes123
Published: 23 May 2012
... survival factors BAFF and APRIL in mucosa from patients with GPA. We detected APRIL production by the granulomas and giant cells. B cells were proliferating in all cases and persistent for 5 years in biopsies obtained from one patient. However, there was no evidence of B-cell clones from the mucosal...
Journal Article
Rita A. Moura and others
Rheumatology, Volume 50, Issue 2, February 2011, Pages 278–282, https://doi.org/10.1093/rheumatology/keq338
Published: 02 November 2010
... IL-21, pg/ml 261.2 (272.6) 1122.0 (3170.0) 1617.0 (3415.0) 1226.0 (1158.0) 464.7 (1178.0) 246.5 (478.7) 548.3 (454.7) APRIL, ng/ml 6.0 (11.3) 18.8 (19.7) 12.5 (8.7) 23.2 (29.9) 5.9 (5.2) 13.1 (27.6) 26.2 (25.8) BAFF, ng/ml 0.3 (0.6) 0.8 (0.6) 0.5 (0.2) 0.8 (0.3) 0.3 (0.4...
Journal Article
Toshio NORIKURA and others
Bioscience, Biotechnology, and Biochemistry, Volume 72, Issue 5, 23 May 2008, Pages 1183–1189, https://doi.org/10.1271/bbb.70586
Published: 23 May 2008
.... These ndings leukemia cells,7) but its anticancer function, especially suggest that BME has possible therapeutic potential in its anti-tumor-proliferative activity, has not been de ned hepatoma cancer patients and that depletion of cellular thus far. APRIL is an important mechanism in the growth- inhibitory e...
Journal Article
Joris Deene
Journal of Intellectual Property Law & Practice, Volume 2, Issue 10, October 2007, Pages 692–698, https://doi.org/10.1093/jiplp/jpm146
Published: 31 August 2007
... of Appeal of 13 April 2006 and the Antwerp Court of Appeal of 19 December 2005 reflect this division. Practical significance There can be no doubt that legal security is under serious threat, both from the developers of software and from potential infringers. The time is right to put a preliminary...
Journal Article
Y. H. Lee and others
Rheumatology, Volume 46, Issue 8, August 2007, Pages 1274–1276, https://doi.org/10.1093/rheumatology/kem093
Published: 14 June 2007
...Y. H. Lee; F. Ota; X. Kim-Howard; K. M. Kaufman; S. K. Nath Interestingly, the APRIL gene is located on chromosome 17p13.1, a genomic location that has been known to be the linkage area in European-American families with vitiligo-related SLE and the hypothetical putative gene is known...
Journal Article
A. Kawasaki and others
Rheumatology, Volume 46, Issue 5, May 2007, Pages 776–782, https://doi.org/10.1093/rheumatology/kem019
Published: 16 February 2007
..., Tsukuba, Ibaraki 305-8575, Japan. E-mail: [email protected] 5 11 2006 9 1 2007 While the role of BLyS in B cell survival, differentiation and activation is established, functions of APRIL remain less defined. Recombinant APRIL stimulates B and T cell proliferation [ 7 ] and APRIL...
Journal Article
Jun Tsukada and others
International Immunology, Volume 17, Issue 9, September 2005, Pages 1167–1178, https://doi.org/10.1093/intimm/dxh294
Published: 09 August 2005
..., SOCS1 expression during DC maturation plays a role in surveillance in controlling the aberrant expansion of abnormal DC subset to maintain homeostasis of immune system. antigen presentation CD8 dendritic cell SOCS1 APC    antigen-presenting cell APRIL    a proliferation-inducing ligand BLyS/ BAFF...
Journal Article
Min Zhang and others
International Immunology, Volume 17, Issue 8, August 2005, Pages 1081–1092, https://doi.org/10.1093/intimm/dxh287
Published: 06 July 2005
...Min Zhang; King-Hung Ko; Queenie Lai Kwan Lam; Cherry Kam Chun Lo; Gopesh Srivastava; Bojian Zheng; Yu-Lung Lau; Liwei Lu apoptosis autoimmunity B lymphocytes cytokine dendritic cells APRIL    a proliferation-inducing ligand BAFF    B cell activation factor BAFF-R    B cell activation factor...
Journal Article
Xin Zhang and others
International Immunology, Volume 17, Issue 6, June 2005, Pages 779–788, https://doi.org/10.1093/intimm/dxh259
Published: 20 May 2005
... to PCs. BAFF BAFF receptors B cell differentiation follicular dendritic cells APRIL    a proliferation-inducing ligand BAFF    B cell-activating factor of the tumor necrosis factor family BCMA    B cell maturation antigen CD40L    CD40 ligand DAPI    4′,6-diamidino-2-phenylindole DRC-1...
Journal Article
T. Koyama and others
Rheumatology, Volume 42, Issue 8, August 2003, Pages 980–985, https://doi.org/10.1093/rheumatology/keg270
Published: 01 August 2003
...T. Koyama; H. Tsukamoto; K. Masumoto; D. Himeji; K. Hayashi; M. Harada; T. Horiuchi 8 1 2003 2 9 2002 © British Society for Rheumatology 2003 Abstract Objective. We investigated the association of gene polymorphisms in APRIL, a new member of the TNF family...